OHI - Omega Healthcare Investors, Inc.
NYSE
->
Real Estate
->
REIT—Healthcare Facilities
Hunt Valley,
United States
Type: Equity
OHI price evolution
OHI
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $39.13 | $363.03 | $444.73 | |
| Short term investments | ||||
| Net receivables | $251.74 | $240.79 | $234.25 | $226.54 |
| Inventory | ||||
| Total current assets | $594.18 | $275.98 | $596.03 | $669.36 |
| Long term investments | ||||
| Property, plant & equipment | $6291.56 | $5877.23 | $5834.3 | $5875.94 |
| Goodwill & intangible assets | $643.79 | $643.78 | $643.9 | |
| Total noncurrent assets | ||||
| Total investments | $1808.07 | $1710.68 | $1684.9 | |
| Total assets | $9571.87 | $8848.55 | $9011.85 | $9117.4 |
| Current liabilities | ||||
| Accounts payable | ||||
| Deferred revenue | ||||
| Short long term debt | ||||
| Total current liabilities | $304.14 | $276.83 | $283.1 | $276.18 |
| Long term debt | $4858.2 | $4660.6 | $5028.15 | $5067.32 |
| Total noncurrent liabilities | ||||
| Total debt | $4660.6 | $5028.15 | $5067.32 | |
| Total liabilities | $5363.93 | $4947.96 | $5311.26 | $5355.11 |
| Shareholders' equity | ||||
| Retained earnings | -$3361.67 | -$3300.09 | -$3247.93 | -$3150.48 |
| Other shareholder equity | $62.74 | $34.34 | $31.85 | $29.34 |
| Total shareholder equity | $3710.9 | $3513.89 | $3574.58 | |
| (in millions $) | 31 Dec 2023 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $444.73 | $300.64 | $24.41 | $167.56 |
| Short term investments | ||||
| Net receivables | $226.54 | $186.03 | $263.07 | $245.07 |
| Inventory | ||||
| Total current assets | $669.36 | $483.13 | $283.61 | $408.6 |
| Long term investments | ||||
| Property, plant & equipment | $5875.94 | $6537.49 | $6789.09 | $6705.24 |
| Goodwill & intangible assets | $643.9 | $643.15 | $651.42 | $651.74 |
| Total noncurrent assets | ||||
| Total investments | $1684.9 | $412.7 | $1510.53 | $1564.16 |
| Total assets | $9117.4 | $9405.16 | $9638.48 | $9497.45 |
| Current liabilities | ||||
| Accounts payable | ||||
| Deferred revenue | ||||
| Short long term debt | ||||
| Total current liabilities | $276.18 | $315.05 | $240.28 | $242.3 |
| Long term debt | $5067.32 | $5286.83 | $5253.54 | $5169.25 |
| Total noncurrent liabilities | ||||
| Total debt | $5067.32 | $5286.83 | $5253.54 | $5169.25 |
| Total liabilities | $5355.11 | $5795.8 | $5530.25 | $5460.84 |
| Shareholders' equity | ||||
| Retained earnings | -$3150.48 | -$2748.59 | -$2542.43 | -$2321.36 |
| Other shareholder equity | $29.34 | $20.32 | -$2.2 | -$12.77 |
| Total shareholder equity | $3574.58 | $3609.37 | $3906.84 | $3841.88 |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $252.75 | $243.3 | $239.32 | |
| Cost of revenue | $3.75 | $3.8 | $3.21 | |
| Gross Profit | $249 | $239.5 | $236.11 | |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $22.15 | $21.53 | $18.53 | |
| Total operating expenses | $106.34 | $103.98 | $135.23 | |
| Operating income | $142.65 | $135.52 | $100.88 | |
| Income from continuing operations | ||||
| EBIT | $169.81 | $127.76 | $118.59 | |
| Income tax expense | $1.98 | $2.58 | $4.16 | |
| Interest expense | $53.97 | $57.82 | $59.43 | |
| Net income | ||||
| Net income | $113.86 | $67.36 | $55 | |
| Income (for common shares) | $113.86 | $67.36 | $55 | |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Jan 2022 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $949.74 | $878.24 | $892.38 | |
| Cost of revenue | $15.03 | $15.5 | $12.32 | |
| Gross Profit | $934.72 | $862.74 | $880.07 | |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $81.5 | $69.4 | $59.89 | |
| Total operating expenses | $543.03 | $550.92 | $499.24 | |
| Operating income | $391.69 | $311.82 | $380.82 | |
| Income from continuing operations | ||||
| EBIT | $483.96 | $664.73 | $387.64 | |
| Income tax expense | $6.25 | $4.56 | $4.92 | |
| Interest expense | $235.53 | $233.24 | $223.39 | |
| Net income | ||||
| Net income | $242.18 | $426.93 | $159.33 | |
| Income (for common shares) | $242.18 | $426.93 | $159.33 | |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Net income | $113.86 | $67.36 | $55 | |
| Operating activities | ||||
| Depreciation | $74.23 | $74.56 | $75.67 | |
| Business acquisitions & disposals | $0.05 | $0.88 | $5.62 | |
| Stock-based compensation | $9.19 | $9.23 | $8.76 | |
| Total cash flows from operations | $184.1 | $151.47 | $164.98 | |
| Investing activities | ||||
| Capital expenditures | -$114.62 | -$24.62 | $242.37 | |
| Investments | -$93.98 | -$25.34 | -$137.39 | |
| Total cash flows from investing | -$389.43 | -$208.52 | -$47.45 | $111.32 |
| Financing activities | ||||
| Dividends paid | -$504 | -$165.96 | -$164.76 | -$164.57 |
| Sale and purchase of stock | $242.84 | $32.35 | $8.66 | |
| Net borrowings | -$369.75 | -$41.88 | -$227.74 | |
| Total cash flows from financing | -$217.09 | -$299.2 | -$186.02 | -$389.79 |
| Effect of exchange rate | $1.64 | -$0.28 | $0.3 | $0.3 |
| Change in cash and equivalents | -$84.42 | -$323.89 | -$81.7 | -$113.19 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | $242.18 | $426.93 | $416.74 | $159.33 |
| Operating activities | ||||
| Depreciation | $319.68 | $332.41 | $342.01 | $329.92 |
| Business acquisitions & disposals | -$3.54 | $3.21 | $1.65 | -$3.74 |
| Stock-based compensation | $35.07 | $27.3 | $21.41 | $18.82 |
| Total cash flows from operations | $617.74 | $625.73 | $722.14 | $708.26 |
| Investing activities | ||||
| Capital expenditures | $240.07 | $464.71 | -$437.36 | -$31 |
| Investments | -$244.06 | -$26.32 | -$94.46 | -$55.22 |
| Total cash flows from investing | -$0.77 | $442.85 | -$524.17 | -$89.06 |
| Financing activities | ||||
| Dividends paid | -$643.87 | -$632.89 | -$637.65 | -$612.31 |
| Sale and purchase of stock | $336.4 | -$134.16 | $274.01 | $151.86 |
| Net borrowings | -$227.92 | $8.11 | $96.82 | $14.05 |
| Total cash flows from financing | -$473.31 | -$789.45 | -$341.12 | -$485.55 |
| Effect of exchange rate | $0.43 | -$2.9 | $0.01 | $0.53 |
| Change in cash and equivalents | $144.09 | $276.23 | -$143.15 | $134.18 |
News
Fundamentals
| Market cap | $10.75B |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 268.23M |
| Revenue | N/A |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | N/A |
| Revenue Q/Q | N/A |
| Revenue Y/Y | N/A |
| P/E ratio | N/A |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | N/A |
|---|---|
| ROA | N/A |
| ROE | N/A |
| Debt/Equity | 1.50 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 1.95 |
| Quick ratio | N/A |